[Modification of the radiation reaction using Tanderil].
D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001943:Breast Neoplasms / Q000532:radiotherapy; D002986:Clinical Trials as Topic; D004890:Erythema / Q000209:etiology; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000532:radiotherapy; D010653:Phenylbutazone / Q000494:pharmacology*; D011837:Radiation-Protective Agents; D011878:Radiotherapy / Q000009:adverse effects*; D012867:Skin / Q000528:radiation effects*; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy
D000893:Anti-Inflammatory Agents; D011837:Radiation-Protective Agents; D010653:Phenylbutazone
Zur Beeinflussung von Strahlenreaktionen durch Tanderil.